ARTW vs TOMZ
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
ARTW exhibits weak financial health with a Piotroski F-Score of 2/9, indicating significant operational and financial distress. The absence of an Altman Z-Score raises concern about potential bankruptcy risk, especially given negative operating margins and declining revenue. While the stock trades below its Graham Number ($3.42) and has a low Price/Book ratio, these value indicators are undermined by deteriorating fundamentals, including a 17.9% YoY revenue decline and negative operating margin. The lack of analyst coverage and neutral insider activity further limit conviction. Overall, the company appears fundamentally challenged despite some apparent undervaluation.
TOMZ exhibits critical financial distress, highlighted by a Piotroski F-Score of 1/9 and a severe accumulated deficit of $58.1 million. While the company maintains a strong gross margin (54.60%), it is unable to translate this into operating profitability, with an operating margin of -161.87%. The balance sheet is highly leveraged with a Debt/Equity ratio of 5.82 and a dangerously low Quick Ratio of 0.25, indicating a liquidity crisis. Despite a single analyst's 'strong buy' rating and a high price target, the fundamental data and a -85% 5-year price trend suggest a high risk of insolvency or further dilution.
Compare Another Pair
Related Comparisons
ARTW vs TOMZ: Head-to-Head Comparison
This page compares Art's-Way Manufacturing Co., Inc. (ARTW) and TOMI Environmental Solutions, Inc. (TOMZ) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.